BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008.
Genome Research is a peer-reviewed scientific journal published by Cold Spring Harbor Laboratory Press. Disregarding review journals, Genome Research ranks 2nd in the category 'Genetics and Genomics' after Nature Genetics. The focus of the journal is on research that provides novel insights into the genome biology of all organisms, including advances in genomic medicine. This scope includes genome structure and function, comparative genomics, molecular evolution, genome-scale quantitative and population genetics, proteomics, epigenomics, and systems biology. The journal also features interesting gene discoveries and reports of cutting-edge computational biology and high-throughput biology methodologies. New data in these areas are published as research papers, or methods and resource reports that provide novel information on technologies or tools that will be of interest to a broad readership. The journal was established in 1991 as PCR Methods and Applications and obtained its current title in 1995. According to the Journal Citation Reports, the journal has a 2020 impact factor of 9.043, which peaked in 2014 at 14.630.
The European Molecular Biology Organization (EMBO) is a professional, non-profit organization of more than 1,800 life scientists. Its goal is to promote research in life science and enable international exchange between scientists. It co-funds courses, workshops and conferences, publishes five scientific journals and supports individual scientists. The organization was founded in 1964 and is a founding member of the Initiative for Science in Europe. As of 2022 the Director of EMBO is Fiona Watt, a stem cell researcher, professor at King's College London and a group leader at the European Molecular Biology Laboratory.
Nature Medicine is a monthly peer-reviewed medical journal published by Nature Portfolio covering all aspects of medicine. It was established in 1995. The journal seeks to publish research papers that "demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results". As with other Nature journals, there is no external editorial board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. The editor-in-chief is João Monteiro.
EF5 is a nitroimidazole derivative used in oncology research. Due to its similarity in chemical structure to etanidazole, EF5 binds in cells displaying hypoxia.
Karen B. Avraham is an Israeli-American human geneticist and the first female Dean of the Tel Aviv University's Faculty of Medicine. Born in Canada in 1962, Avraham moved to the US at a young age. Her research focuses on the discovery and characterization of genes responsible for hereditary hearing loss.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), formerly the Society of Nuclear Medicine, is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging. SNMMI's mission is to improve human health by advancing molecular imaging and therapy.
Genes & Development is a peer-reviewed scientific journal covering molecular biology, molecular genetics, cell biology, and development. It was established in 1987 and is published twice monthly by Cold Spring Harbor Laboratory Press in association with The Genetics Society.
The Journal of Molecular Medicine is a monthly, peer-reviewed, scientific journal published by Springer Science+Business Media. It covers all aspects of human biology and pathophysiology. The emphasis is on the progress and precision now possible in the understanding, prevention, diagnosis and treatment of human diseases. The employment of molecular biology and gene technology has enhanced the understanding of human diseases and has created a new branch of research known as "molecular medicine".
Positron emission tomography–magnetic resonance imaging (PET–MRI) is a hybrid imaging technology that incorporates magnetic resonance imaging (MRI) soft tissue morphological imaging and positron emission tomography (PET) functional imaging.
Cherenkov luminescence imaging (CLI) is an emerging imaging modality, similar to bioluminescence imaging, that captures visible photons emitted by Cherenkov radiation. It basically is the optical imaging of radiotracers that emit charged particles traveling faster than the phase velocity of light in that particular medium. It can be used to quickly evaluate radio tracers in preclinical research but also to obtain clinical images in patients. While radioactivity itself can not be modified, the emitted light provides an opportunity to generate radioactivity-based activatable or "smart" imaging agents that sense for example enzymatic activity.
The European Association of Nuclear Medicine (EANM) is the leading professional organisation for nuclear medicine in Europe. Established in 1985, the EANM serves as an umbrella organisation comprising national societies, affiliated societies, physicians, scientists, and individual members working in nuclear medicine or related fields. It is also dedicated to the promotion of nuclear medicine amongst international organisations like the International Atomic Energy Agency, EU institutions like the European Union and the general public.
Clinical Chemistry and Laboratory Medicine is a monthly peer-reviewed scientific journal that is published by De Gruyter.
The Journal of Nuclear Medicine is a monthly peer-reviewed medical journal published by Society of Nuclear Medicine and Molecular Imaging that covers research on all aspects of nuclear medicine, including molecular imaging.
Frank Michael Bengel is a German professor and nuclear medicine physician. He is the current director of the Department of Nuclear Medicine at the Hannover Medical School.
The European Heart Journal: Cardiovascular Imaging is a peer-reviewed medical journal published by Oxford University Press, on behalf of the European Society of Cardiology. The first issue was published in March 2000 with the former name of European Journal of Echocardiography. The journal adopted the current name European Heart Journal: Cardiovascular Imaging in 2012, and is part of the European Heart Journal series of journals.
Sandip Basu is an Indian physician of Nuclear Medicine and the Head, Nuclear Medicine Academic Program at the Radiation Medicine Centre. He is also the Dean-Academic (Health-Sciences), BARC at Homi Bhabha National Institute and is known for his services and research in Nuclear Medicine, particularly on Positron emission tomography diagnostics and Targeted Radionuclide Therapy in Cancer. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Nuclear Medicine in 2012.
Angelika Bischof-Delaloye is a former emeritus professor at the University Lausanne, Lausanne, Switzerland.
